Immunotherapy for HPV associated cancer – what have we learnt?

Guest speaker Professor Ian Frazer from UQDI will be presenting Immunotherapy for HPV associated cancer – what have we learnt?

Wednesday 24 March, 9:30-10:30am, TRI Auditorium and via Zoom: https://uqz.zoom.us/j/89437090918

Email Jessica Iannotti for the Zoom password. 

Ian Frazer’s Bio: Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers.  He is recognised as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Jingang Medicine (Aus) Pty Ltd, working on new vaccine technologies, and is a board member of several companies and not for profit organisations. He was the inaugural president of the Australian Academy of Health and Medical Sciences, and a member of the Australian National Science and Technology Council. He chairs the Australian Medical Research Advisory Board of the Medical Research Future Fund.